Novateor Research Laboratories (BOM:542771) EBIT : ₹1.23 Mil (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Novateor Research Laboratories EBIT?

Novateor Research Laboratories's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹0.70 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹1.23 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Novateor Research Laboratories's annualized ROC % for the quarter that ended in Sep. 2024 was -2.40%. Novateor Research Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 1.39%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Novateor Research Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 0.65%.

Novateor Research Laboratories EBIT Historical Data

The historical data trend for Novateor Research Laboratories's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novateor Research Laboratories EBIT Chart

Novateor Research Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

Get a 7-Day Free Trial

0.27

0.17

-2.60

0.45

0.75

Novateor Research Laboratories Semi-Annual Data
	Mar17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EBIT	Get a 7-Day Free Trial										0.07	0.39	0.22	0.53	0.70

Competitive Comparison of Novateor Research Laboratories's EBIT

For the Household & Personal Products subindustry, Novateor Research Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novateor Research Laboratories's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Novateor Research Laboratories's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Novateor Research Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹1.23 Mil.

Novateor Research Laboratories (BOM:542771) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Novateor Research Laboratories's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	-3.356 * ( 1 - 26.55% )	/	( (98.249	+	107.165)	/ 2 )
=	-2.464982	/	102.707
=	-2.40 %

where

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	104.589	-	5.445	-	( 0.895	-	max(0, 11.963	-	75.175	+	0.895	))
=	98.249

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	111.343	-	3.577	-	( 0.601	-	max(0, 9.434	-	80.115	+	0.601	))
=	107.165

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Novateor Research Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1.392	/	( ( (28.699 + max(68.686, 0))	+	(30.513 + max(72.066, 0)) )	/	2 )
=	1.392	/	( ( 97.385	+	102.579 )	/	2 )
=	1.392	/	99.982
=	1.39 %

where Working Capital is:

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.235	+	6.979	+	56.066)	-	(5.445	+	0	+	0.149)
=	68.686

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.872	+	6.42	+	61.016)	-	(3.577	+	0	+	3.665)
=	72.066

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Novateor Research Laboratories's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	1.226	/	187.995
	=	0.65 %

Novateor Research Laboratories EBIT Related Terms

Thank you for viewing the detailed overview of Novateor Research Laboratories's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Novateor Research Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Novateor Research Laboratories Ltd (BOM:542771) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Anandnagar Cross Road, 100 Feet Ring Road, 1026, Dev Atelier, Opposite Dev Auram, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.novateor.com

Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.

Novateor Research Laboratories Headlines

No Headlines